Zealand Pharma A/S/DKrZEAL
07:00
09:00
11:00
12:55
14:55
1D1W1MYTD1Y5YMAX
About Zealand Pharma A/S
Ticker
DKrZEAL
Sector
Primary listing
CSE
Employees
424
Headquarters
Søborg, Denmark
Website
ZEAL Metrics
BasicAdvanced
kr 33B
4.94
kr 93.68
0.60
-
Price and volume
Market cap
kr 33B
Beta
0.6
52-week high
kr 520.00
52-week low
kr 410.10
Average daily volume
333K
Financial strength
Current ratio
15.092
Quick ratio
15.083
Long term debt to equity
2.431
Total debt to equity
2.543
Interest coverage (TTM)
224.24%
Profitability
EBITDA (TTM)
7,195.203
Gross margin (TTM)
100.06%
Net profit margin (TTM)
73.34%
Operating margin (TTM)
78.88%
Effective tax rate (TTM)
7.40%
Revenue per employee (TTM)
kr 21,490,000
Management effectiveness
Return on assets (TTM)
32.86%
Return on equity (TTM)
53.44%
Valuation
Price to earnings (TTM)
4.943
Price to revenue (TTM)
3.594
Price to book
2.1
Price to tangible book (TTM)
2.1
Price to free cash flow (TTM)
4.352
Free cash flow yield (TTM)
22.98%
Free cash flow per share (TTM)
106.404
Growth
Revenue change (TTM)
2,375.69%
Earnings per share change (TTM)
-892.73%
3-year revenue growth (CAGR)
344.16%
10-year revenue growth (CAGR)
61.01%
3-year earnings per share growth (CAGR)
50.65%
10-year earnings per share growth (CAGR)
28.12%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Zealand Pharma A/S stock?
Zealand Pharma A/S (ZEAL) has a market cap of DKr33B as of October 25, 2025.
What is the P/E ratio for Zealand Pharma A/S stock?
The price to earnings (P/E) ratio for Zealand Pharma A/S (ZEAL) stock is 4.94 as of October 25, 2025.
Does Zealand Pharma A/S stock pay dividends?
No, Zealand Pharma A/S (ZEAL) stock does not pay dividends to its shareholders as of October 25, 2025.
When is the next Zealand Pharma A/S dividend payment date?
Zealand Pharma A/S (ZEAL) stock does not pay dividends to its shareholders.
What is the beta indicator for Zealand Pharma A/S?
Zealand Pharma A/S (ZEAL) has a beta rating of 0.6. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.